Mar 10, 2021
What the COVID relief package allocates for vaccines
Share Now on:
There's about $14 billion to speed up the distribution and administration of vaccines across the country, and $46 billion to expand COVID testing and to enhance contact tracing capabilities. Plus, the Nasdaq's correction this week and wider trends about where investors are putting their money and why.
Segments From this episode
COVID relief package provides $14 billion for things like vaccine distribution
Marketplace's Nancy Marshall-Genzer has more.
"The definition of volatility in the market"
By the end of Monday, the tech-heavy Nasdaq fell 2.4%, putting it in correction territory, down 10% from a recent high. Then, Tuesday comes around, and the Nasdaq posts its biggest rise in four months, up 3.7%. Susan Schmidt, head of U.S. equities at Aviva Investors, says that in some ways this movement is "very understandable." "Remember that that Nasdaq index has been our outperformer of the indices, not only last year but the last two years. Last year that index was up over 40%." Schmidt says investors are torn whether to continue putting money into tech stocks, which have done so well over the course of the pandemic, or if they want to diversify over other industries, too, with stimulus on the way and other businesses slated to benefit over the course of a recovery.
David Brancaccio Host
Nicole Childers Executive Producer
Victoria Craig Producer, BBC
Stephen Ryan Producer, BBC
Jonathan Frewin Producer, BBC
Daniel Shin Producer
Jay Siebold Engineer
Brian Allison Engineer
Alex Schroeder Digital producer
Meredith Garretson Producer
Erika Soderstrom Producer/Director